CG MedTech Co.,Ltd. (KOSDAQ:056090)

CG MedTech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26,939	12,648	22,499	12,336	5,091
Short-Term Investments	5,841	94.04	40,006	2,689	4,749
Trading Asset Securities	1,519	1,605	12,482	5,161	-
Cash & Short-Term Investments	34,299	14,348	74,987	20,187	9,840
Cash Growth	139.05%	-80.87%	271.46%	105.15%	65.91%
Accounts Receivable	5,435	6,517	7,457	6,768	6,532
Other Receivables	300.71	336.98	391.72	154.59	56.74
Receivables	6,532	7,032	8,230	8,841	7,193
Inventory	12,270	11,515	10,617	10,245	9,198
Prepaid Expenses	165.95	243.37	68.97	28.31	53.24
Other Current Assets	813.14	417.09	918.37	392.68	1,758
Total Current Assets	54,079	33,556	94,821	39,694	28,043
Property, Plant & Equipment	32,695	29,996	28,270	18,020	17,743
Long-Term Investments	433.2	508.26	2,940	2,734	2,305
Goodwill	1,524	-	-	-	-
Other Intangible Assets	3,027	1,258	1,458	1,642	1,447
Long-Term Deferred Tax Assets	16.51	133.72	107.11	59.35	-
Long-Term Deferred Charges	124.5	160.5	132.61	262.34	465
Other Long-Term Assets	14,767	12,214	12,446	12,390	12,413
Total Assets	107,200	79,098	141,439	75,062	64,432
Accounts Payable	2,455	1,484	1,221	2,713	1,220
Accrued Expenses	535.4	431.32	588.42	613.34	946.78
Short-Term Debt	1,863	3,243	64,918	14,208	8,010
Current Portion of Long-Term Debt	99.67	0	0	0	10,670
Current Portion of Leases	346.3	478.88	360.71	275.24	131.01
Current Income Taxes Payable	13.41	-	13.12	62.1	-
Other Current Liabilities	6,554	3,100	5,589	4,389	3,154
Total Current Liabilities	11,867	8,737	72,690	22,261	24,132
Long-Term Debt	1,448	-	-	15,158	5,000
Long-Term Leases	674.19	644.81	730.88	333.71	53.34
Long-Term Deferred Tax Liabilities	4,879	3,721	3,423	25.69	33.68
Other Long-Term Liabilities	1,155	5,553	6,258	5,962	5,212
Total Liabilities	20,434	19,198	83,760	46,284	37,347
Common Stock	51,630	39,440	39,440	4,660	4,073
Additional Paid-In Capital	79,736	68,260	68,260	65,431	59,414
Retained Earnings	-57,197	-57,127	-58,332	-39,532	-34,430
Treasury Stock	-	-	-	-1,983	-1,983
Comprehensive Income & Other	12,997	9,617	8,337	-31.47	11.45
Total Common Equity	87,165	60,189	57,705	28,544	27,085
Minority Interest	-398.93	-289.72	-25.91	233.38	-
Shareholders' Equity	86,766	59,900	57,679	28,778	27,085
Total Liabilities & Equity	107,200	79,098	141,439	75,062	64,432
Total Debt	4,431	4,367	66,009	29,975	23,864
Net Cash (Debt)	29,867	9,981	8,977	-9,788	-14,024
Net Cash Growth	199.24%	11.18%	-	-	-
Net Cash Per Share	500.36	128.66	134.93	-219.88	-365.46
Filing Date Shares Outstanding	25.85	78.88	78.88	46.05	40.18
Total Common Shares Outstanding	25.85	78.88	78.88	46.05	40.18
Working Capital	42,212	24,819	22,131	17,433	3,912
Book Value Per Share	3372.13	763.05	731.55	619.82	674.08
Tangible Book Value	82,613	58,931	56,247	26,902	25,638
Tangible Book Value Per Share	3196.06	747.10	713.06	584.16	638.08
Land	24,613	22,718	21,203	10,460	10,460
Buildings	4,924	4,795	4,795	4,809	4,809
Machinery	17,814	15,946	14,864	14,680	13,223
Construction In Progress	79.71	50	227.5	115.81	16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.